메뉴 건너뛰기




Volumn 12, Issue 7, 2012, Pages 502-503

Linezolid for multidrug-resistant tuberculosis

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; STREPTOMYCIN;

EID: 84862749539     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70137-8     Document Type: Letter
Times cited : (8)

References (18)
  • 1
    • 56749180450 scopus 로고    scopus 로고
    • Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis
    • Dietze R, Hadad DJ, McGee B, et al. Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis. Am J Respir Crit Care Med 2008, 178:1180-1185.
    • (2008) Am J Respir Crit Care Med , vol.178 , pp. 1180-1185
    • Dietze, R.1    Hadad, D.J.2    McGee, B.3
  • 2
    • 65649089528 scopus 로고    scopus 로고
    • Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model
    • Williams KN, Stover CK, Zhu T, et al. Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model. Antimicrob Agents Chemother 2009, 53:1314-1319.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 1314-1319
    • Williams, K.N.1    Stover, C.K.2    Zhu, T.3
  • 4
    • 69249137544 scopus 로고    scopus 로고
    • A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
    • Migliori GB, Eker B, Richardson MD, et al. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. Eur Respir J 2009, 34:387-393.
    • (2009) Eur Respir J , vol.34 , pp. 387-393
    • Migliori, G.B.1    Eker, B.2    Richardson, M.D.3
  • 5
    • 67650730258 scopus 로고    scopus 로고
    • Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis
    • Koh W-J, Kwon OJ, Gwak H, et al. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. J Antimicrob Chemother 2009, 64:388-391.
    • (2009) J Antimicrob Chemother , vol.64 , pp. 388-391
    • Koh, W.-J.1    Kwon, O.J.2    Gwak, H.3
  • 6
    • 40549129680 scopus 로고    scopus 로고
    • Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis
    • Yew WW, Chau CH, Wen KH Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2008, 12:345-346.
    • (2008) Int J Tuberc Lung Dis , vol.12 , pp. 345-346
    • Yew, W.W.1    Chau, C.H.2    Wen, K.H.3
  • 7
    • 84860330843 scopus 로고    scopus 로고
    • Linezolid, an effective, safe and cheap drug in MDR-TB treatment failure patients in India
    • Singla R, Caminero JA, Jaiswal A, et al. Linezolid, an effective, safe and cheap drug in MDR-TB treatment failure patients in India. Eur Respir J 2012, 39:956-962.
    • (2012) Eur Respir J , vol.39 , pp. 956-962
    • Singla, R.1    Caminero, J.A.2    Jaiswal, A.3
  • 8
    • 44449177016 scopus 로고    scopus 로고
    • In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years
    • Huang T-S, Liu Y-C, Sy C-L, Chen Y-S, Tu H-Z, Chen B-C In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years. Antimicrob Agents Chemother 2008, 52:2226-2227.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 2226-2227
    • Huang, T.-S.1    Liu, Y.-C.2    Sy, C.-L.3    Chen, Y.-S.4    Tu, H.-Z.5    Chen, B.-C.6
  • 9
    • 73949101816 scopus 로고    scopus 로고
    • Mechanisms of drug resistance in Mycobacterium tuberculosis
    • Zhang Y, Yew WW Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009, 13:1320-1330.
    • (2009) Int J Tuberc Lung Dis , vol.13 , pp. 1320-1330
    • Zhang, Y.1    Yew, W.W.2
  • 10
    • 34547424537 scopus 로고    scopus 로고
    • Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome
    • Narita M, Tsuji BT, Yu VL Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Pharmacotherapy 2007, 27:1189-1197.
    • (2007) Pharmacotherapy , vol.27 , pp. 1189-1197
    • Narita, M.1    Tsuji, B.T.2    Yu, V.L.3
  • 11
    • 11244293686 scopus 로고    scopus 로고
    • Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong
    • Chang KC, Leung CC, Tam CM Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis 2004, 8:1492-1498.
    • (2004) Int J Tuberc Lung Dis , vol.8 , pp. 1492-1498
    • Chang, K.C.1    Leung, C.C.2    Tam, C.M.3
  • 12
    • 33847699798 scopus 로고    scopus 로고
    • 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is 'science' enough to tackle the epidemic?
    • Migliori GB, Loddenkemper R, Blasi F, Raviglione MC 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is 'science' enough to tackle the epidemic?. Eur Respir J 2007, 29:423-427.
    • (2007) Eur Respir J , vol.29 , pp. 423-427
    • Migliori, G.B.1    Loddenkemper, R.2    Blasi, F.3    Raviglione, M.C.4
  • 13
    • 0035992065 scopus 로고    scopus 로고
    • Hematologic effects of linezolid: summary of clinical experience
    • Gerson SL, Kaplan SL, Bruss JB, et al. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother 2002, 46:2723-2726.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 2723-2726
    • Gerson, S.L.1    Kaplan, S.L.2    Bruss, J.B.3
  • 15
    • 84864512573 scopus 로고    scopus 로고
    • Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients
    • published online May 8.
    • Koh W-J, Kang YR, Jeon K, et al. Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients. J Antimicrob Chemother 2012, published online May 8. 10.1093/jac/dks078.
    • (2012) J Antimicrob Chemother
    • Koh, W.-J.1    Kang, Y.R.2    Jeon, K.3
  • 16
    • 80053082369 scopus 로고    scopus 로고
    • Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis
    • Villar M, Sotgiu G, D'Ambrosio L, et al. Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis. Eur Respir J 2011, 38:730-733.
    • (2011) Eur Respir J , vol.38 , pp. 730-733
    • Villar, M.1    Sotgiu, G.2    D'Ambrosio, L.3
  • 17
    • 84862735973 scopus 로고    scopus 로고
    • Extensively drug-resistant tuberculosis (XDR-TB) treated with daily/intermittent linezolid. Chicago, USA, 51st Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, USA; Sept 17-20. L1-1488.
    • Chang KC, Yew WW, Cheung SW, Leung CC. Extensively drug-resistant tuberculosis (XDR-TB) treated with daily/intermittent linezolid. Chicago, USA, 51st Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, USA; Sept 17-20, 2011. L1-1488.
    • (2011)
    • Chang, K.C.1    Yew, W.W.2    Cheung, S.W.3    Leung, C.C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.